Imatinib mesylate 400 MG tab 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F46HH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,024
Award facts
- Contract value 100% obligated
- $1,024.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,024.44 to AmerisourceBergen Drug Corp for Imatinib Mesylate 400 mg tablets (30-count supply) on December 9, 2025, with an ultimate completion date of December 10, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The recurring delivery orders, such as this one for Imatinib Mesylate—a critical oncology medication—demonstrate the company's role in sustaining the Defense Health Agency's pharmaceutical inventory and supporting U.S. military medical readiness.
Quick answers
Who was awarded contract SPE2DR26F46HH?
SPE2DR26F46HH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F46HH worth?
The government has obligated $1,024 on SPE2DR26F46HH.
Is contract SPE2DR26F46HH an order under another contract?
Yes. SPE2DR26F46HH is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F46HH competed?
The extent of competition for SPE2DR26F46HH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award